Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

  • Quoted phrase not found.
1.

The identification of Lynch syndrome in Congolese colorectal cancer patients.

Poaty H, Aba Gandzion C, Soubeyran I, Gassaye D, Peko JF, Nkoua Bon JB, Gombé Mbalawa C.

Bull Cancer. 2017 Oct;104(10):831-839. doi: 10.1016/j.bulcan.2017.08.005. Epub 2017 Oct 6.

PMID:
28988047
2.

Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).

Ramchander NC, Ryan NA, Crosbie EJ, Evans DG.

BMC Med Genet. 2017 Apr 5;18(1):40. doi: 10.1186/s12881-017-0391-x.

3.

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.

Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB.

Cancer. 2017 May 15;123(10):1721-1730. doi: 10.1002/cncr.30498. Epub 2017 Jan 13.

PMID:
28085182
4.

Universal tumor screening for Lynch syndrome: health-care providers' perspectives.

Bombard Y, Rozmovits L, Sorvari A, Daly C, Carroll JC, Kennedy E, Rabeneck L, Baxter NN.

Genet Med. 2017 May;19(5):568-574. doi: 10.1038/gim.2016.150. Epub 2016 Oct 6.

PMID:
27711070
5.

Primary Colon Adenosquamous Carcinoma in a Patient With Lynch Syndrome: A New Histologic Subtype Associated With Microsatellite Instability?

Duncan VE, Harada S, Stevens TM.

Int J Surg Pathol. 2016 Oct;24(7):653-5. doi: 10.1177/1066896916659539. Epub 2016 Jul 15.

PMID:
27422471
6.

Risk-reduction surgery in pediatric surgical oncology: A perspective.

Sandoval JA, Fernandez-Pineda I, Malkan AD.

J Pediatr Surg. 2016 Apr;51(4):675-87. doi: 10.1016/j.jpedsurg.2016.01.004. Epub 2016 Feb 3. Review.

PMID:
26898681
7.

Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test.

Hang JF, Li AF, Chang SC, Liang WY.

Histopathology. 2016 Jul;69(1):54-62. doi: 10.1111/his.12903. Epub 2016 Jan 19.

PMID:
26588428
8.

Epidemioclinical Feature of Early-Onset Colorectal Cancer at-Risk for Lynch Syndrome in Central Iran.

Zeinalian M, Hashemzadeh-Chaleshtori M, Akbarpour MJ, Emami MH.

Asian Pac J Cancer Prev. 2015;16(11):4647-52.

9.

Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.

Shia J.

Semin Diagn Pathol. 2015 Sep;32(5):352-61. doi: 10.1053/j.semdp.2015.02.018. Epub 2015 Feb 4. Review.

10.

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.

Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, Lloyd A, Ma YP, Dobbins SE, Houlston RS.

J Clin Oncol. 2015 Feb 10;33(5):426-32. doi: 10.1200/JCO.2014.56.5689. Epub 2015 Jan 5.

PMID:
25559809
11.

Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).

Newton K, Jorgensen NM, Wallace AJ, Buchanan DD, Lalloo F, McMahon RF, Hill J, Evans DG.

J Med Genet. 2014 Dec;51(12):789-96. doi: 10.1136/jmedgenet-2014-102552. Epub 2014 Oct 3.

12.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
13.

Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma.

Pai RK, Shadrach BL, Carver P, Heald B, Moline J, Church J, Kalady MF, Burke CA, Plesec TP, Lai KK, Gonzalo DH, Pai RK.

Am J Surg Pathol. 2014 Apr;38(4):518-25. doi: 10.1097/PAS.0000000000000148.

PMID:
24625416
14.

Clinical features and prognosis in colorectal cancer patients with different ethnicities in Northwest China.

Yusup A, Wang HJ, Rahmutula A, Sayim P, Zhao ZL, Zhang GQ.

World J Gastroenterol. 2013 Nov 7;19(41):7183-8. doi: 10.3748/wjg.v19.i41.7183.

15.

Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- mice.

Pussila M, Sarantaus L, Dermadi Bebek D, Valo S, Reyhani N, Ollila S, Päivärinta E, Peltomäki P, Mutanen M, Nyström M.

PLoS One. 2013 Oct 8;8(10):e76865. doi: 10.1371/journal.pone.0076865. eCollection 2013.

16.

BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.

Toon CW, Chou A, DeSilva K, Chan J, Patterson J, Clarkson A, Sioson L, Jankova L, Gill AJ.

Mod Pathol. 2014 May;27(5):644-50. doi: 10.1038/modpathol.2013.200. Epub 2013 Oct 25.

17.

Excess of extracolonic non-endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1.

Lin-Hurtubise KM, Yheulon CG, Gagliano RA Jr, Lynch HT.

J Surg Oncol. 2013 Dec;108(7):433-7. doi: 10.1002/jso.23413. Epub 2013 Oct 10.

PMID:
24122742
18.

BRAF mutation in sporadic colorectal cancer and Lynch syndrome.

Thiel A, Heinonen M, Kantonen J, Gylling A, Lahtinen L, Korhonen M, Kytölä S, Mecklin JP, Orpana A, Peltomäki P, Ristimäki A.

Virchows Arch. 2013 Nov;463(5):613-21. doi: 10.1007/s00428-013-1470-9. Epub 2013 Aug 21.

PMID:
23963522
19.

Familial risk of small intestinal carcinoid and adenocarcinoma.

Kharazmi E, Pukkala E, Sundquist K, Hemminki K.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):944-9. doi: 10.1016/j.cgh.2013.02.025. Epub 2013 Mar 15.

PMID:
23500615
20.

Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome.

van der Klift HM, Tops CM, Hes FJ, Devilee P, Wijnen JT.

Hum Mutat. 2012 Jul;33(7):1051-5. doi: 10.1002/humu.22092. Epub 2012 Apr 30.

PMID:
22461402

Supplemental Content

Loading ...
Support Center